Vicore Pharma Holding AB (publ) (STO: VICO)
Sweden
· Delayed Price · Currency is SEK 8.45
+0.19 (2.30%)
Dec 30, 2024, 5:29 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 104.24M SEK in the twelve months ending September 30, 2024.
Revenue (ttm)
104.24M
Revenue Growth
n/a
P/S Ratio
9.94
Revenue / Employee
3.59M
Employees
24
Market Cap
2.17B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 25.44B |
| Sectra AB | 3.14B |
| Getinge AB | 33.59B |
| Camurus AB | 1.69B |
| Vitrolife AB | 3.56B |
| Bonesupport Holding AB | 814.46M |
| Elekta AB | 17.72B |
| Vimian Group AB | 3.99B |